0001104659-20-076463.txt : 20200624
0001104659-20-076463.hdr.sgml : 20200624
20200624164902
ACCESSION NUMBER: 0001104659-20-076463
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200624
DATE AS OF CHANGE: 20200624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rajah Vignesh
CENTRAL INDEX KEY: 0001815042
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 20986125
MAIL ADDRESS:
STREET 1: HENRIKSHOJ 8
STREET 2: ROOM 4
CITY: VEDBAEK
STATE: G7
ZIP: DK-2950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
a4.xml
4
X0306
4
2020-06-23
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001815042
Rajah Vignesh
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK
NY
10169
0
1
0
0
SVP & CMO
Employee Stock Option (right to buy)
48.67
2020-06-23
4
A
0
40000
0
A
2030-06-23
Common stock
40000
40000
D
Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
The stock option shall vest and become exercisable as to 25% of the shares subject to the option on June 23, 2021, and thereafter vests and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Vignesh Rajah
2020-06-24